PTC Therapeutics shares are trading lower after multiple firms downgraded the stock and lowered their respective price targets.
Portfolio Pulse from Benzinga Newsdesk
PTC Therapeutics shares are trading lower after multiple firms downgraded the stock and lowered their respective price targets.
September 18, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
PTC Therapeutics' stock is trading lower due to downgrades and lowered price targets by multiple firms.
The downgrades and lowered price targets by multiple firms directly impact PTC Therapeutics' stock, leading to a decrease in its trading price. This is a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100